End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.33 USD | -16.01% |
|
-40.85% | -98.78% |
May. 21 | Earnings Flash (SBFM) SUNSHINE BIOPHARMA Posts Q1 Revenue $7.5M | MT |
May. 20 | Sunshine Biopharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Financials (USD)
Sales 2024 * | 44.94M | Sales 2025 * | 100M | Capitalization | 6.25M |
---|---|---|---|---|---|
Net income 2024 * | - | Net income 2025 * | 11M | EV / Sales 2024 * | 0.14 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 0.06 x |
P/E ratio 2024 * |
-0.33
x | P/E ratio 2025 * |
0.01
x | Employees | 44 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.5% |
1 day | -16.01% | ||
1 week | -40.85% | ||
Current month | -47.33% | ||
1 month | -63.31% | ||
3 months | -93.40% | ||
6 months | -98.63% | ||
Current year | -98.78% |
![Extreme 0.2811](/images/extremecours_fleche.png)
![Extreme 0.2811](/images/extremecours_fleche.png)
![Extreme 0.2811](/images/extremecours_fleche.png)
![Extreme 0.2811](/images/extremecours_fleche.png)
![Extreme 0.2811](/images/extremecours_fleche.png)
![Extreme 0.2811](/images/extremecours_fleche.png)
![Extreme 0.2811](/images/extremecours_fleche.png)
Managers | Title | Age | Since |
---|---|---|---|
Steve Slilaty
CEO | Chief Executive Officer | 71 | 09-10-14 |
Camille Sebaaly
DFI | Director of Finance/CFO | 62 | 09-10-14 |
Marc Beaudoin
COO | Chief Operating Officer | - | Jan. 24 |
Members of the board | Title | Age | Since |
---|---|---|---|
David Natan
BRD | Director/Board Member | 70 | 22-01-31 |
Steve Slilaty
CEO | Chief Executive Officer | 71 | 09-10-14 |
Camille Sebaaly
DFI | Director of Finance/CFO | 62 | 09-10-14 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-14 | 0.33 | -16.01% | 3,708,382 |
24-06-13 | 0.3929 | +37.76% | 23,458,339 |
24-06-12 | 0.2852 | -15.50% | 3,798,658 |
24-06-11 | 0.3375 | -10.64% | 2,370,944 |
24-06-10 | 0.3777 | -32.30% | 5,205,471 |
End-of-day quote Nasdaq, June 13, 2024
More quotes![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-98.78% | 6.25M | |
+50.70% | 791B | |
+41.96% | 630B | |
-7.15% | 350B | |
+18.77% | 328B | |
+8.79% | 298B | |
+18.02% | 246B | |
+1.27% | 225B | |
+11.95% | 218B | |
+3.68% | 160B |
- Stock Market
- Equities
- SBFM Stock